» Articles » PMID: 31126594

An Updated Algorithm Recommendation for the Management of Knee Osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Abstract

Objectives: The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) sought to revisit the 2014 algorithm recommendations for knee osteoarthritis (OA), in light of recent efficacy and safety evidence, in order to develop an updated stepwise algorithm that provides practical guidance for the prescribing physician that is applicable in Europe and internationally.

Methods: Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) process, a summary of evidence document for each intervention in OA was provided to all members of an ESCEO working group, who were required to evaluate and vote on the strength of recommendation for each intervention. Based on the evidence collected, and on the strength of recommendations afforded by consensus of the working group, the final algorithm was constructed.

Results: An algorithm for management of knee OA comprising a stepwise approach and incorporating consensus on 15 treatment recommendations was prepared by the ESCEO working group. Both "strong" and "weak" recommendations were afforded to different interventions. The algorithm highlights the continued importance of non-pharmacological interventions throughout the management of OA. Benefits and limitations of different pharmacological treatments are explored in this article, with particular emphasis on safety issues highlighted by recent literature analyses.

Conclusions: The updated ESCEO stepwise algorithm, developed by consensus from clinical experts in OA and informed by available evidence for the benefits and harms of various treatments, provides practical, current guidance that will enable clinicians to deliver patient-centric care in OA practice.

Citing Articles

Exploration and verification of circulating diagnostic biomarkers in osteoarthritis based on machine learning.

Wang X, Liu T, Sheng Y, Qiu C, Zhang Y, Liu Y Front Genet. 2025; 16:1513675.

PMID: 40034747 PMC: 11872907. DOI: 10.3389/fgene.2025.1513675.


Effectiveness and Safety of SYSADOAs Used in Eastern and Western Regions for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-SYSADOAs Are Effective and Safe for Knee OA.

Park Y, Kim J Medicina (Kaunas). 2025; 61(2).

PMID: 40005447 PMC: 11857085. DOI: 10.3390/medicina61020331.


Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: A Systematic Umbrella Review.

Glinkowski W, Tomaszewski W J Clin Med. 2025; 14(4).

PMID: 40004802 PMC: 11856182. DOI: 10.3390/jcm14041272.


Clinical phenotypes and associated factors in knee osteoarthritis in an African black population.

Sougue C, Diallo M, Bayala Y, Ayouba Tinni I, Kabore F, Zabsonre Tiendrebeogo W Osteoarthr Cartil Open. 2025; 7(1):100570.

PMID: 39991671 PMC: 11847051. DOI: 10.1016/j.ocarto.2025.100570.


Efficacy and safety of loxoprofen sodium cataplasms in the treatment of osteoarthritis: A randomized, multicenter study.

Lei Y, Liu Z, Jin X, Gao G, Luo S, Gao X Biomed Rep. 2025; 22(4):57.

PMID: 39991003 PMC: 11843193. DOI: 10.3892/br.2025.1935.